Breast carcinoma amplified sequence 3 Antibody Blocking Peptide Summary
| Description |
A blocking peptide containing 18 amino acids near the amino terminus of human BCAS3 . Source: Synthetic (Accession #: EAW51415) |
| Source |
Synthetic |
| Protein/Peptide Type |
Antibody Blocking Peptide |
| Gene |
BCAS3 |
| Purity |
N/A |
Applications/Dilutions
| Dilutions |
|
| Application Notes |
This peptide is useful as a blocking peptide for NBP1-77125. For further blocking peptide related protocol, click here. |
Packaging, Storage & Formulations
| Storage |
Store at -20C. Avoid freeze-thaw cycles. |
| Buffer |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
| Preservative |
0.02% Sodium Azide |
| Concentration |
0.2 mg/ml |
| Purity |
N/A |
Alternate Names for Breast carcinoma amplified sequence 3 Antibody Blocking Peptide
Background
BCAS3 acts as an ERalpha coactivator in breast cancer cells. It has been demonstrated that PELP1, a newly described ERalpha coregulator, is recruited to BCAS3 chromatin and activates its expression. Analysis of the BCAS3 sequence for functional motifs and evidence from biochemical fractionation suggested that BCAS3 acts as a transcriptional coactivator. Results from chromatin immunoprecipitation, reporter assays, and expression studies further validated the coactivator function of BCAS3 for ERalpha. BCAS3 physically associated with histone H3 and histone acetyltransferase complex protein P/CAF and possessed histone acetyltransferase activity.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are
guaranteed for 3 months from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu, Mu
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
Species: Hu, Mu
Applications: ELISA, ICC/IF, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, WB
Species: Hu, Mu
Applications: ELISA, IHC, IP, WB
Species: Bv, Ca, Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, Simple Western, WB
Species: Hu
Applications: ELISA
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P
Species: Hu
Applications: Flow, IHC, mIF
Species: Hu, Mu, Rt
Applications: ELISA, Flow, WB
Species: Hu
Applications: ICC, IHC, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Hu
Applications: ICC/IF, IHC, IHC-P, IP, WB
Species: Hu, Mu
Applications: IHC, IHC-P, IP, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB
Species: Hu
Applications: IHC, IHC-P, WB
Species: Hu
Applications: AC
Publications for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP) (0)
There are no publications for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP) (0)
There are no reviews for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP) (0)
Additional Breast carcinoma amplified sequence 3 Products
Research Areas for Breast carcinoma amplified sequence 3 Peptide (NBP1-77125PEP)
Find related products by research area.
|
Blogs on Breast carcinoma amplified sequence 3